Chemotherapy delivered straight to the belly: new hope for stomach cancer patients

NCT ID NCT07133490

Recruiting now Disease control Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 05, 2026 · Last updated Jun 18, 2026 · Updated 3 times

Summary

This study tests a new treatment for stomach cancer that has spread to the lining of the belly (peritoneal metastases). About 55 patients will receive chemotherapy directly into the abdomen along with standard intravenous chemotherapy, and possibly immunotherapy or targeted therapy based on their tumor markers. The goal is to see if this combination is feasible and can help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERITONEAL METASTASES FROM GASTRIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Antoni van Leeuwenhoek
RECRUITING

Amsterdam, Netherlands

Contact Phone: •••-•••-••••
Catharina Hospital
RECRUITING

Eindhoven, Netherlands

Contact Phone: •••-•••-••••
Erasmus MC, University Medical Center Rotterdam
RECRUITING

Rotterdam, Netherlands

Contact Phone: •••-•••-••••

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm peritoneal carcinomatosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERITONEAL METASTASES FROM GASTRIC CANCER